BriaCell Therapeutics Corp. BCT.TO
As ofNov 13, 2026, 3:25 PM EST
- YTD
- -50.10%
- 1 year
- -64.44%
- Market cap
- 42.70M
- EPS (ttm)
- -9.66
- Shares out
- 44.20M
- Forward P/E
- -1.41
- YTD return
- -50.10%
- 1-year return
- -64.44%
- Volume
- 1.85K
- Avg volume
- 7.30K
- Open
- 4.86
- Previous close
- 4.90
- Day's range
- 4.76 – 4.89
- 52-week range
- 3.68 – 18.00
- Beta
- 1.82
5D +0.81 (+17.61%)
Key statistics
- Enterprise value
- 15.11M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -10.83M
- Total cash
- 862.09K
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.03%
- 50-day average
- 1.10
- 200-day average
- 1.74
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- Website
- briacell.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BCT.TO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Lustig (Marc) | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Feb 16, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Lynwood Capital Management Inc. | 3.61% | 1,597,750 | 1.21M | Mar 30, 2024 |
| Vontobel Holding Limited | 0.18% | 80,000 | 60.80K | Sep 29, 2024 |
| HRT Financial LP | 0.17% | 74,286 | 56.46K | Sep 29, 2024 |
| Onyx Bridge Wealth Group, LLC | 0.11% | 50,000 | 38.00K | Sep 29, 2024 |
| Group One Trading, L.P. | 0.09% | 37,885 | 28.79K | Sep 29, 2024 |
| Summit Trail Advisors, LLC | 0.08% | 35,000 | 26.60K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.02% | 7,229 | 5.49K | Oct 30, 2024 |
